28. Distribution of laboratory-confirmed wild poliovirus type 1 cases (N = 476) European Region, 2010 (458 in Tajikistan, 14 in Russia, three in Turkmenistan, and one in Kazakhstan)
29.
30.
31.
32.
33.
34. Rubella Complications Arthralgia or arthritis children adult female Thrombocytopenic purpura Encephalitis Neuritis Orchitis rare up to 70% 1/3000 cases 1/6,000 cases rare rare
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46. Condition Diarrhea Otitis media Pneumonia Encephalitis Hospitalization Death Percent reported 8 7 6 0.1 18 0.2 Measles Complications Based on 1985-1992 surveillance data
47.
48.
49.
50.
51.
52.
53.
54. Mumps Complications CNS involvement Orchitis Pancreatitis Deafness Death 15% of clinical cases 20%-50% in post- pubertal males 2%-5% 1/20,000 1-3/10,000
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
Editor's Notes
Increased risk of VAPP in immunodeficient children and persons >18 years of age.
![[object Object],D-r Mitova MU-Sofia](https://image.slidesharecdn.com/vaccine3-polio-111024113601-phpapp01/85/Vaccine3-polio-1-320.jpg)
![Poliomyelitis ,[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)